← back to search

Ralf Gold

Lead Discovery Center (Germany) · DE
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, and Hereditary Neurological Disorders.
h-index
101
citations
47,748
works
1,257
NIH funding
primary concept
email

Recent publications

Beyond antibodies in GAD65 autoimmunity: Reframing pathogenesis through intrathecal B-T cell cross-talk.
2026cited by 0position: contributordoi
Treatment-free remission in MS: long-term disease control with cladribine tablets.
2026cited by 0position: contributordoi
Longitudinal changes of choroid plexus volumes and MRI ratios in multiple sclerosis.
2026cited by 0position: contributordoi
Psoriasis under B-cell depleting therapies in multiple sclerosis: a retrospective multicenter analysis.
2026cited by 0position: contributordoi
A Novel 3D Semi-Automated Full Quantification Technique for Detection of Intraneural Phospho-α-Synuclein in Skin Biopsies.
2026cited by 0position: contributordoi
Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study.
2026cited by 0position: contributordoi
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
2026cited by 0position: contributordoi
CD19-targeted CAR T-cell therapy for treatment-refractory autoimmune neuropathies
The Lancet Neurology 2025cited by 13position: lastdoi
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson’s disease: a randomized double-blind prospective study
Scientific Reports 2025cited by 7position: middledoi
Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome.
2025cited by 5position: contributordoi
Anti-CD19 CAR T-Cell Therapy in Advanced Stiff-Person Syndrome and Concomitant Myasthenia Gravis.
2025cited by 3position: contributordoi
Chimeric antigen receptor T-cell therapy for stiff-person syndrome: bridging innovation and clinical challenges in neuroimmunology.
2025cited by 1position: contributordoi
Education Research: Teaching Neurologic Emergencies Through Serious Games: A Randomized Comparative Intervention Study.
2025cited by 1position: contributordoi
Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome.
2024cited by 38position: contributordoi
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories
Science Translational Medicine 2024cited by 38position: middledoi
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis
Neurology 2024cited by 36position: middledoi
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
2024cited by 31position: contributordoi
Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis.
2024cited by 26position: contributordoi
Apheresis therapies in MOGAD: a retrospective study of 117 therapeutic interventions in 571 attacks
Journal of Neurology Neurosurgery & Psychiatry 2024cited by 22position: middledoi
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.
2024cited by 17position: contributordoi
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?
Therapeutic Advances in Neurological Disorders 2024cited by 17position: middledoi
Rapid differentiation of MOGAD and MS after a single optic neuritis
Journal of Neurology 2024cited by 10position: middledoi
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology 2024cited by 9position: middledoi
Modeling extrahepatic hepatitis E virus infection in induced human primary neurons.
2024cited by 6position: contributordoi
Neonatal B-Cell Levels and Infant Health in Newborns Potentially Exposed to Anti-CD20 Monoclonal Antibodies During Pregnancy or Lactation.
2024cited by 4position: contributordoi
Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disease.
2024cited by 4position: contributordoi
Automatic estimation of brain parenchymal fraction in patients with multple sclerosis: a comparison between synthetic MRI and an established automated brain segmentation software based on FSL.
2024cited by 4position: contributordoi
Eomesodermin-expressing CD4+ Th cells and association with pregnancy in multiple sclerosis.
2024cited by 1position: contributordoi
Presentation and Outcome in S1P-RM and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: A Multicenter Cohort Study.
2024cited by 1position: contributordoi
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology 2023cited by 219position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 28 papers (2020–2026)Frauke Zipp · Department of Physics, Mathematics and Informatics10 papers (2012–2023)Heinz Wiendl · JDSU (United States)10 papers (2012–2024)Aiden Haghikia · Universitätsklinikum Erlangen9 papers (2012–2025)Simon Faissner · Ruhr-University7 papers (2022–2026)Martin Stangel · Novartis (Switzerland)7 papers (2012–2019)Hans‐Peter Hartung · The University of Sydney6 papers (2012–2024)Jeremias Motte · Elsevier, Inc.6 papers (2021–2025)I. Ayzenberg · Heinrich Heine University Düsseldorf5 papers (2024–2025)Tania Kümpfel · Imperial College London5 papers (2014–2022)Björn Tackenberg · Johannes Gutenberg University Mainz5 papers (2015–2021)Sven G. Meuth · Antea Group (France)5 papers (2015–2024)Kerstin Hellwig · Antea Group (France)5 papers (2012–2021)Ludwig Kappos · Department of Biomedicine Basel5 papers (2012–2024)Amit Bar‐Or · University of California System4 papers (2012–2023)Ralf A. Linker · Klinik und Poliklinik für Neurologie4 papers (2014–2024)Bernd C. Kieseier · Novartis (Switzerland)4 papers (2012–2024)Lars Tönges · St. Josef-Hospital4 papers (2021–2026) · 4 papers (2021–2026)Christoph Kleinschnitz · Essen University Hospital4 papers (2021–2026)